{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:18:01Z","timestamp":1763644681486,"version":"build-2065373602"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10822-025-00627-y","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T19:08:02Z","timestamp":1752520082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cHeptadecanol\u201d a phytochemical multi-target inhibitor of SMYD3 &amp; GFPT2 proteins in non-small cell lung cancer: an in-silico &amp; in-vitro investigation"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-7917","authenticated-orcid":false,"given":"Lokesh","family":"Ravi","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1010-4199","authenticated-orcid":false,"given":"Pratishtha","family":"Jain","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1882-4860","authenticated-orcid":false,"given":"Ajith Kumar","family":"K","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-5513","authenticated-orcid":false,"given":"Jeevan Kumar","family":"M","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6652-7240","authenticated-orcid":false,"given":"Mukti","family":"Panda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4682-4861","authenticated-orcid":false,"given":"Harshitha","family":"S","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0803-1197","authenticated-orcid":false,"given":"Mohammed Abdul","family":"Kareem","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0803-1372","authenticated-orcid":false,"given":"K. Sivani Yelchuri","family":"Sai","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8514-4458","authenticated-orcid":false,"given":"Ayman","family":"Fathima","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8517-3685","authenticated-orcid":false,"given":"V.","family":"Jensha","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9671-8426","authenticated-orcid":false,"given":"Adarsh Anurag","family":"Rai","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5667-9899","authenticated-orcid":false,"given":"Hida Amal","family":"Faizal","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0645-3892","authenticated-orcid":false,"given":"Shrivats","family":"S R","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4790-7045","authenticated-orcid":false,"given":"Ankitha","family":"Ajith","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6920-8378","authenticated-orcid":false,"given":"Derick","family":"Yesudas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0770-000X","authenticated-orcid":false,"given":"Vaarruni","family":"S","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3973-0244","authenticated-orcid":false,"given":"Varshini","family":"S","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7288-9624","authenticated-orcid":false,"given":"Raksha","family":"Shetty","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1913-8732","authenticated-orcid":false,"given":"Aditi","family":"Jha","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1093-2192","authenticated-orcid":false,"given":"Gundlapalli Saradha","family":"Janaki","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8153-7551","authenticated-orcid":false,"given":"Varsha Hannah","family":"George","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9799-1386","authenticated-orcid":false,"given":"Stalin","family":"Nithaniyal","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-8043","authenticated-orcid":false,"given":"Mookkandi Palsamy","family":"Kesavan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-1429","authenticated-orcid":false,"given":"Sajith Ahamed","family":"A","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0603-6608","authenticated-orcid":false,"given":"Sankara Narayanan","family":"A","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"627_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","volume":"143","author":"NM Raghavendra","year":"2018","unstructured":"Raghavendra NM, Pingili D, Kadasi S et al (2018) Dual or multi-targeting inhibitors: the next generation anticancer agents. Eur J Med Chem 143:1277\u20131300. https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.021","journal-title":"Eur J Med Chem"},{"key":"627_CR2","doi-asserted-by":"publisher","first-page":"e40262","DOI":"10.1371\/journal.pone.0040262","volume":"7","author":"J-J Lu","year":"2012","unstructured":"Lu J-J, Pan W, Hu Y-J, Wang Y-T (2012) Multi-target drugs: the trend of drug research and development. PLoS ONE 7:e40262. https:\/\/doi.org\/10.1371\/journal.pone.0040262","journal-title":"PLoS ONE"},{"key":"627_CR3","doi-asserted-by":"publisher","first-page":"112974","DOI":"10.1016\/j.biopha.2022.112974","volume":"150","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Li M, Li H, Chen L (2022) Entrectinib, a new multi-target inhibitor for cancer therapy. Biomed Pharmacother 150:112974. https:\/\/doi.org\/10.1016\/j.biopha.2022.112974","journal-title":"Biomed Pharmacother"},{"key":"627_CR4","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.2174\/0929867327666200102115720","volume":"27","author":"Y Ling","year":"2020","unstructured":"Ling Y, Liu J, Qian J et al (2020) Recent advances in multi-target drugs targeting protein kinases and histone deacetylases in cancer therapy. Curr Med Chem 27:7264\u20137288. https:\/\/doi.org\/10.2174\/0929867327666200102115720","journal-title":"Curr Med Chem"},{"key":"627_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann GR, Leh\u00e1r J, Keith CT (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12:34\u201342. https:\/\/doi.org\/10.1016\/j.drudis.2006.11.008","journal-title":"Drug Discov Today"},{"key":"627_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.phrs.2015.09.019","volume":"102","author":"L Tao","year":"2015","unstructured":"Tao L, Zhu F, Xu F et al (2015) Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs. Pharmacol Res 102:123\u2013131. https:\/\/doi.org\/10.1016\/j.phrs.2015.09.019","journal-title":"Pharmacol Res"},{"key":"627_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","volume":"22","author":"A Doostmohammadi","year":"2024","unstructured":"Doostmohammadi A, Jooya H, Ghorbanian K et al (2024) Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Commun Signal 22:228. https:\/\/doi.org\/10.1186\/s12964-024-01607-9","journal-title":"Cell Commun Signal"},{"key":"627_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/acschembio.4c00028","volume":"19","author":"E Laudadio","year":"2024","unstructured":"Laudadio E, Mangano L, Minnelli C (2024) Chemical Scaffolds for the clinical development of mutant-selective and reversible fourth-generation EGFR-TKIs in NSCLC. ACS Chem Biol 19:839\u2013854. https:\/\/doi.org\/10.1021\/acschembio.4c00028","journal-title":"ACS Chem Biol"},{"key":"627_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"627_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/lungindia.lungindia_333_19","volume":"37","author":"A Mohan","year":"2020","unstructured":"Mohan A, Garg A, Gupta A et al (2020) Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center. Lung India 37:190. https:\/\/doi.org\/10.4103\/lungindia.lungindia_333_19","journal-title":"Lung India"},{"key":"627_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.annonc.2021.06.001","volume":"32","author":"M Reck","year":"2021","unstructured":"Reck M, Carbone DP, Garassino M, Barlesi F (2021) Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches. Ann Oncol 32:1101\u20131110. https:\/\/doi.org\/10.1016\/j.annonc.2021.06.001","journal-title":"Ann Oncol"},{"key":"627_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3892\/ijo.2020.5095","volume":"57","author":"J Li","year":"2020","unstructured":"Li J, Zhao L, Pan Y et al (2020) SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer. Int J Oncol 57:756\u2013766. https:\/\/doi.org\/10.3892\/ijo.2020.5095","journal-title":"Int J Oncol"},{"key":"627_CR13","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4203208\/v1","author":"J Liu","year":"2024","unstructured":"Liu J, Ao L, Jia W et al (2024) GFPT2 controls immune evasion in EGFR-mutated non-small cell lung cancer. Biol Sci. https:\/\/doi.org\/10.21203\/rs.3.rs-4203208\/v1","journal-title":"Biol Sci"},{"key":"627_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.59566\/IJBS.2009.5001","volume":"5","author":"A Amin","year":"2009","unstructured":"Amin A, Gali-Muhtasib H, Ocker M, Schneider-Stock R (2009) Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci: IJBS 5:1","journal-title":"Int J Biomed Sci: IJBS"},{"key":"627_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5425485","volume":"2022","author":"AJ Siddiqui","year":"2022","unstructured":"Siddiqui AJ, Jahan S, Singh R et al (2022) Plants in anticancer drug discovery: from molecular mechanism to chemoprevention. Biomed Res Int 2022:1\u201318. https:\/\/doi.org\/10.1155\/2022\/5425485","journal-title":"Biomed Res Int"},{"key":"627_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cbi.2014.10.028","volume":"234","author":"CA Morgan","year":"2015","unstructured":"Morgan CA, Hurley TD (2015) Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1. Chem Biol Interact 234:29\u201337. https:\/\/doi.org\/10.1016\/j.cbi.2014.10.028","journal-title":"Chem Biol Interact"},{"key":"627_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41467-020-14524-5","volume":"11","author":"S Ruegenberg","year":"2020","unstructured":"Ruegenberg S, Horn M, Pichlo C et al (2020) Loss of GFAT-1 feedback regulation activates the hexosamine pathway that modulates protein homeostasis. Nat Commun 11:687. https:\/\/doi.org\/10.1038\/s41467-020-14524-5","journal-title":"Nat Commun"},{"key":"627_CR18","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.1074\/jbc.M115.709832","volume":"291","author":"W Fu","year":"2016","unstructured":"Fu W, Liu N, Qiao Q et al (2016) Structural basis for substrate preference of SMYD3, a SET domain-containing Protein Lysine Methyltransferase. J Biol Chem 291:9173\u20139180. https:\/\/doi.org\/10.1074\/jbc.M115.709832","journal-title":"J Biol Chem"},{"key":"627_CR19","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1073\/pnas.1404639111","volume":"111","author":"JC Hunter","year":"2014","unstructured":"Hunter JC, Gurbani D, Ficarro SB et al (2014) In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C. Proc Natl Acad Sci 111:8895\u20138900. https:\/\/doi.org\/10.1073\/pnas.1404639111","journal-title":"Proc Natl Acad Sci"},{"key":"627_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19\/COVER","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19\/COVER","journal-title":"Methods Mol Biol"},{"key":"627_CR21","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1038\/s41598-020-60221-0","volume":"10","author":"ACC de Sousa","year":"2020","unstructured":"de Sousa ACC, Combrinck JM, Maepa K, Egan TJ (2020) Virtual screening as a tool to discover new \u03b2-haematin inhibitors with activity against malaria parasites. Sci Rep 10:3374. https:\/\/doi.org\/10.1038\/s41598-020-60221-0","journal-title":"Sci Rep"},{"key":"627_CR22","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.1080\/07391102.2021.1969286","volume":"40","author":"C Egbuna","year":"2022","unstructured":"Egbuna C, Patrick-Iwuanyanwu KC, Onyeike EN et al (2022) FMS-like tyrosine kinase-3 (FLT3) inhibitors with better binding affinity and ADMET properties than sorafenib and gilteritinib against acute myeloid leukemia: in silico studies. J Biomol Struct Dyn 40:12248\u201312259. https:\/\/doi.org\/10.1080\/07391102.2021.1969286","journal-title":"J Biomol Struct Dyn"},{"key":"627_CR23","doi-asserted-by":"publisher","first-page":"105675","DOI":"10.1016\/j.bioorg.2022.105675","volume":"121","author":"S-C Yen","year":"2022","unstructured":"Yen S-C, Chen L-C, Huang H-L et al (2022) Identification of a dual FLT3 and MNK2 inhibitor for acute myeloid leukemia treatment using a structure-based virtual screening approach. Bioorg Chem 121:105675. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105675","journal-title":"Bioorg Chem"},{"key":"627_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2317988","author":"L Ravi","year":"2024","unstructured":"Ravi L, Kumar KA, G R SK, et al (2024) Behenic Acid as a multi-target inhibiting antibacterial phytochemical against Vibrio parahaemolyticus and Aeromonas hydrophila for effective management of aquaculture infections: an in-silico, in-vitro & in-vivo experimentation. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2317988","journal-title":"J Biomol Struct Dyn"},{"key":"627_CR25","doi-asserted-by":"publisher","first-page":"10057","DOI":"10.1080\/07391102.2023.2255271","volume":"42","author":"L Ravi","year":"2024","unstructured":"Ravi L, Kumar KA, Kumari GRS et al (2024) Stearyl palmitate a multi-target inhibitor against breast cancer: in-silico, in-vitro & in-vivo approach. J Biomol Struct Dyn 42:10057\u201310074. https:\/\/doi.org\/10.1080\/07391102.2023.2255271","journal-title":"J Biomol Struct Dyn"},{"key":"627_CR26","unstructured":"Lilkova E (2015) The PyMOL Molecular Graphics System, Version 2.0 Schrodinger, LLC"},{"key":"627_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. \u201cProtein Engineering, Design and Selection\u201d 8:127\u2013134. https:\/\/doi.org\/10.1093\/protein\/8.2.127","journal-title":"\u201cProtein Engineering, Design and Selection\u201d"},{"key":"627_CR28","unstructured":"Bergdorf M, Avi R-M, Xinyi G, et al (2021) Desmond\/GPU performance as of April 2021. DE Shaw Research, Tech Rep"},{"key":"627_CR29","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.3390\/molecules28052199","volume":"28","author":"R Akter","year":"2023","unstructured":"Akter R, Yang DU, Ahn JC et al (2023) Comparison of in vitro estrogenic activity of Polygoni multiflori Radix and Cynanchi wilfordii Radix via the enhancement of ER\u03b1\/\u03b2 expression in MCF7 cells. Molecules 28:2199. https:\/\/doi.org\/10.3390\/molecules28052199","journal-title":"Molecules"},{"key":"627_CR30","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/molecules27154798","volume":"27","author":"J-S Kim","year":"2022","unstructured":"Kim J-S, Lim H, Seo J-Y et al (2022) GPR183 regulates 7\u03b1,25-Dihydroxycholesterol-induced Oxiapoptophagy in L929 mouse fibroblast cell. Molecules 27:4798. https:\/\/doi.org\/10.3390\/molecules27154798","journal-title":"Molecules"},{"key":"627_CR31","doi-asserted-by":"publisher","first-page":"121098","DOI":"10.1016\/j.saa.2022.121098","volume":"274","author":"M Kumari","year":"2022","unstructured":"Kumari M, Kamat S, Jayabaskaran C (2022) Usnic acid induced changes in biomolecules and their association with apoptosis in squamous carcinoma (A-431) cells: a flow cytometry, FTIR and DLS spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc 274:121098. https:\/\/doi.org\/10.1016\/j.saa.2022.121098","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"627_CR32","doi-asserted-by":"publisher","first-page":"109661","DOI":"10.1016\/j.intimp.2022.109661","volume":"115","author":"T-T Yu","year":"2023","unstructured":"Yu T-T, Hu J, Li Q-R et al (2023) Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage. Int Immunopharmacol 115:109661. https:\/\/doi.org\/10.1016\/j.intimp.2022.109661","journal-title":"Int Immunopharmacol"},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"e0120401","DOI":"10.1371\/journal.pone.0120401","volume":"10","author":"A Arun","year":"2015","unstructured":"Arun A, Bauml\u00e9 V, Amelot G, Nieberding CM (2015) Selection and validation of reference genes for qRT-PCR expression analysis of candidate genes involved in Olfactory communication in the butterfly Bicyclus anynana. PLoS ONE 10:e0120401. https:\/\/doi.org\/10.1371\/journal.pone.0120401","journal-title":"PLoS ONE"},{"key":"627_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/138920207781386960","volume":"8","author":"SA Deepak","year":"2007","unstructured":"Deepak SA, Kottapalli KR, Rakwal R et al (2007) Real-time PCR: revolutionizing detection and expression analysis of genes. Curr Genomics 8:234\u2013251. https:\/\/doi.org\/10.2174\/138920207781386960","journal-title":"Curr Genomics"},{"key":"627_CR35","doi-asserted-by":"publisher","first-page":"e1000925","DOI":"10.1371\/journal.pcbi.1000925","volume":"6","author":"M Iskar","year":"2010","unstructured":"Iskar M, Campillos M, Kuhn M et al (2010) Drug-induced regulation of target expression. PLoS Comput Biol 6:e1000925. https:\/\/doi.org\/10.1371\/journal.pcbi.1000925","journal-title":"PLoS Comput Biol"},{"key":"627_CR36","doi-asserted-by":"publisher","first-page":"15727","DOI":"10.3390\/IJMS160715727","volume":"16","author":"ES Scarpa","year":"2015","unstructured":"Scarpa ES, Ninfali P (2015) Phytochemicals as innovative therapeutic tools against cancer stem cells. Int J Mol Sci 16:15727\u201315742. https:\/\/doi.org\/10.3390\/IJMS160715727","journal-title":"Int J Mol Sci"},{"key":"627_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11030-022-10590-7","volume":"1","author":"AP Das","year":"2023","unstructured":"Das AP, Agarwal SM (2023) Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. Mol Divers 1:1. https:\/\/doi.org\/10.1007\/S11030-022-10590-7","journal-title":"Mol Divers"},{"key":"627_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/J.COMPBIOMED.2022.106293","author":"W Zhang","year":"2022","unstructured":"Zhang W, Tian W, Wang Y et al (2022) Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking. Comput Biol Med. https:\/\/doi.org\/10.1016\/J.COMPBIOMED.2022.106293","journal-title":"Comput Biol Med"},{"key":"627_CR39","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1515\/chem-2021-0076","volume":"19","author":"N Abutaha","year":"2021","unstructured":"Abutaha N, AL-Zharani M, Alotaibi A et al (2021) In vitro and in vivo investigation of polypharmacology of propolis extract as anticancer, antibacterial, anti-inflammatory, and chemical properties. Open Chem 19:864\u2013874. https:\/\/doi.org\/10.1515\/chem-2021-0076","journal-title":"Open Chem"},{"key":"627_CR40","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.3390\/cimb45050241","volume":"45","author":"SK Niazi","year":"2023","unstructured":"Niazi SK, Basavarajappa DS, Kumaraswamy SH et al (2023) GC-MS based characterization, antibacterial, antifungal and anti-oncogenic activity of ethyl acetate extract of Aspergillus niger strain AK-6 isolated from Rhizospheric soil. Curr Issues Mol Biol 45:3733\u20133756. https:\/\/doi.org\/10.3390\/cimb45050241","journal-title":"Curr Issues Mol Biol"},{"key":"627_CR41","doi-asserted-by":"publisher","first-page":"100208","DOI":"10.1016\/j.crgsc.2021.100208","volume":"4","author":"S Pradhan","year":"2021","unstructured":"Pradhan S, Dubey RC (2021) Molecular docking of a bioactive compound of C. sinensis n-heptadecanol-1 with opportunistic fungi. Current Res Green Sustain Chem 4:100208. https:\/\/doi.org\/10.1016\/j.crgsc.2021.100208","journal-title":"Current Res Green Sustain Chem"},{"key":"627_CR42","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00203-021-02209-6","volume":"203","author":"S Pradhan","year":"2021","unstructured":"Pradhan S, Dubey RC (2021) GC\u2013MS analysis and molecular docking of bioactive compounds of Camellia sinensis and Camellia assamica. Arch Microbiol 203:2501\u20132510. https:\/\/doi.org\/10.1007\/s00203-021-02209-6","journal-title":"Arch Microbiol"},{"key":"627_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/JBCPP.2010.21.1.93","volume":"21","author":"S Mirunalini","year":"2010","unstructured":"Mirunalini S, Krishnaveni M (2010) Therapeutic potential of Phyllanthus emblica (amla): the ayurvedic wonder. J Basic Clin Physiol Pharmacol 21:93\u2013105. https:\/\/doi.org\/10.1515\/JBCPP.2010.21.1.93","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"627_CR44","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1021\/cr078350s","volume":"108","author":"Q-W Shi","year":"2008","unstructured":"Shi Q-W, Su X-H, Kiyota H (2008) Chemical and pharmacological research of the plants in genus Euphorbia. Chem Rev 108:4295\u20134327. https:\/\/doi.org\/10.1021\/cr078350s","journal-title":"Chem Rev"},{"key":"627_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1017\/S0007114509993667","volume":"103","author":"J Epstein","year":"2010","unstructured":"Epstein J, Sanderson IR, MacDonald TT (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103:1545\u20131557. https:\/\/doi.org\/10.1017\/S0007114509993667","journal-title":"Br J Nutr"},{"key":"627_CR46","first-page":"141","volume":"14","author":"JS Jurenka","year":"2009","unstructured":"Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14:141\u2013153","journal-title":"Altern Med Rev"},{"key":"627_CR47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1389450121666200925150022","volume":"22","author":"SJ Uddin","year":"2021","unstructured":"Uddin SJ, Hasan MdF, Afroz M et al (2021) Curcumin and its multi-target function against pain and inflammation: an update of pre-clinical data. Curr Drug Targets 22:656\u2013671. https:\/\/doi.org\/10.2174\/1389450121666200925150022","journal-title":"Curr Drug Targets"},{"key":"627_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/toxins2010128","volume":"2","author":"M-H Teiten","year":"2010","unstructured":"Teiten M-H, Eifes S, Dicato M, Diederich M (2010) Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2:128\u2013162. https:\/\/doi.org\/10.3390\/toxins2010128","journal-title":"Toxins (Basel)"},{"key":"627_CR49","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1182\/blood-2010-10-314260","volume":"117","author":"DJ Straus","year":"2011","unstructured":"Straus DJ, Johnson JL, LaCasce AS et al (2011) Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I\/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood 117:5314\u20135320. https:\/\/doi.org\/10.1182\/blood-2010-10-314260","journal-title":"Blood"},{"key":"627_CR50","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2165\/00003495-200363150-00003","volume":"63","author":"CCP Verstappen","year":"2003","unstructured":"Verstappen CCP, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer. Drugs 63:1549\u20131563. https:\/\/doi.org\/10.2165\/00003495-200363150-00003","journal-title":"Drugs"},{"key":"627_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2989","author":"P Gopi","year":"2022","unstructured":"Gopi P, Singh S, Islam MM et al (2022) Thermodynamic and structural profiles of multi-target binding of vinblastine in solution. J Mol Recog. https:\/\/doi.org\/10.1002\/jmr.2989","journal-title":"J Mol Recog"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00627-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:56:54Z","timestamp":1762451814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00627-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00627-y","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"49"}}